Aardvark Therapeutics Stock

www.aardvarktherapeutics.comHealthcare / BioTech & PharmaFounded: 2017

Aardvark Therapeutics is a biotechnology company striving to develop treatments for metabolic and inflammatory diseases. Specifically, the company focuses on novel small molecule therapeutics that are intended to help activate the gut-to-brain signaling pathways related to hunger and appetite suppression. Aardvark Therapeutics was founded in 2017 by Andreas Niethammer and Tien Lee and is headquartered in San Diego, CA. The company’s main product candidate ARD-101 is an oral compound that aims to act as a bitter taste receptor with the goal of reducing appetite and promoting weight loss.

Register To Buy and Sell Shares

For more details on financing and valuation for Aardvark Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Aardvark Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Aardvark Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Tien Lee MD
Chief Executive Officer
Andreas Niethammer MD, Ph.D
Chief Medical Officer
Bruce Beutler MD
Chief Scientific Advisor
Bryan Jones Ph.D
Chief Operating Officer
Nelson Sun
Chief Financial Officer
Zhenhuan Zheng Ph.D
Chief Research Officer
Dvorit Samid Ph.D
Executive Vice President of Medical Affairs
Anjuli Timmer Ph.D
Chief Development Officer

Board Members

Jeffrey Chi Ph.D
Vickers Venture Partners

Frequently Asked Questions About Aardvark Therapeutics’ Stock

Can you buy Aardvark Therapeutics’ stock?
Aardvark Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Aardvark Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Aardvark Therapeutics’ stock?
Yes, you can sell stock of a private company like Aardvark Therapeutics. Forge can help you sell your Aardvark Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Aardvark Therapeutics’ stock price?
Aardvark Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Aardvark Therapeutics’ private market stock price with Forge Data.
What is Aardvark Therapeutics’ stock ticker symbol?
Aardvark Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Aardvark Therapeutics Raises $85M in Series C Financing
In a series C funding led by Decheng Capital, Aardvark raised $85 million.
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.